1. Home
  2. BOLD vs DGHI Comparison

BOLD vs DGHI Comparison

Compare BOLD & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • DGHI
  • Stock Information
  • Founded
  • BOLD 2018
  • DGHI 2017
  • Country
  • BOLD United States
  • DGHI United States
  • Employees
  • BOLD N/A
  • DGHI N/A
  • Industry
  • BOLD
  • DGHI Finance: Consumer Services
  • Sector
  • BOLD
  • DGHI Finance
  • Exchange
  • BOLD Nasdaq
  • DGHI Nasdaq
  • Market Cap
  • BOLD 54.9M
  • DGHI 61.7M
  • IPO Year
  • BOLD 2024
  • DGHI N/A
  • Fundamental
  • Price
  • BOLD $2.65
  • DGHI $1.91
  • Analyst Decision
  • BOLD Buy
  • DGHI Strong Buy
  • Analyst Count
  • BOLD 3
  • DGHI 1
  • Target Price
  • BOLD $22.50
  • DGHI $2.50
  • AVG Volume (30 Days)
  • BOLD 143.3K
  • DGHI 292.9K
  • Earning Date
  • BOLD 11-07-2024
  • DGHI 11-15-2024
  • Dividend Yield
  • BOLD N/A
  • DGHI N/A
  • EPS Growth
  • BOLD N/A
  • DGHI N/A
  • EPS
  • BOLD N/A
  • DGHI N/A
  • Revenue
  • BOLD N/A
  • DGHI $42,146,057.00
  • Revenue This Year
  • BOLD N/A
  • DGHI N/A
  • Revenue Next Year
  • BOLD N/A
  • DGHI N/A
  • P/E Ratio
  • BOLD N/A
  • DGHI N/A
  • Revenue Growth
  • BOLD N/A
  • DGHI 100.56
  • 52 Week Low
  • BOLD $2.33
  • DGHI $0.84
  • 52 Week High
  • BOLD $15.24
  • DGHI $2.49
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • DGHI 52.89
  • Support Level
  • BOLD N/A
  • DGHI $1.62
  • Resistance Level
  • BOLD N/A
  • DGHI $2.23
  • Average True Range (ATR)
  • BOLD 0.00
  • DGHI 0.22
  • MACD
  • BOLD 0.00
  • DGHI -0.02
  • Stochastic Oscillator
  • BOLD 0.00
  • DGHI 52.24

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

Share on Social Networks: